Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in ItalyEBioMedicine 2022 May 05;80(2022)104042, MP Sormani, I Schiavetti, M Inglese, L Carmisciano, A Laroni, C Lapucci, V Visconti, C Serrati, I Gandoglia, T Tassinari, G Perego, G Brichetto, P Gazzola, A Mannironi, ML Stromillo, C Cordioli, D Landi, M Clerico, E Signoriello, E Cocco, J Frau, MT Ferrò, A Di Sapio, L Pasquali, M Ulivelli, F Marinelli, M Pizzorno, G Callari, R Iodice, G Liberatore, F Caleri, AM Repice, S Cordera, MA Battaglia, M Salvetti, D Franciotta, A Uccelli
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.